Clinical Trials
2 trialsNCT05012618 2025-12-24
A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Chugai Pharmaceutical
Phase 1 Terminated
NCT04564417 2024-01-31
First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors
Pierre Fabre Medicament
Phase 1 Terminated